Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anshen granules is a traditional Chinese medicine (TCM) hospital preparation developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine for the treatment of insomnia. The formula is designed to calm the spirit and nourish the heart, addressing the TCM patterns of heart-blood deficiency and liver-qi stagnation often associated with sleep disturbances. The primary active ingredient is typically Semen Ziziphi Spinosae (Suan Zao Ren), which contains jujubosides and flavonoids that exhibit sedative and hypnotic effects. These compounds are believed to interact with the GABAergic system, specifically modulating GABA-A receptors to enhance inhibitory neurotransmission in the brain. The preparation is used clinically to improve sleep quality, reduce sleep latency, and alleviate anxiety-related symptoms in patients. As a hospital-made medicine, it is registered and used within the Guangdong Provincial Hospital of TCM system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Anshen granules.